Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

FDA Alert: AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products

 AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry due to a lack of assurance of sterility. The recalled sterile products have been found to be inconsistent with federal gui...
Continue reading
Topics:
FDA

Closing Gaps in Cannabinoid Research to Make Progress in Pain Management

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, shares his thoughts on closing gaps in cannabinoid research to make progress in pain m...
Continue reading
Topics:

FDA Warns about Serious Breathing Problems with Seizure and Nerve Pain Medicines Gabapentin

The U.S. Food and Drug Administration is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) who have respiratory risk facto...
Continue reading
Topics:

Report from the November 2019 AMA Interim Meeting

The following report was submitted by Robert Wailes, MD, AAPM AMA Delegate The Interim Meeting of the American Medical Association (AMA) House of Delegates (HOD) convened November 16, 2019 in San Diego. I represented the...
Continue reading
Topics:
AMA

Societies Advocate for Spine Intervention Training

AAPM joined nine other medical specialty societies in writing to the Oregon Health Authority urging prerequisite training for the performance of spine interventions.

Continue reading
Topics:

LCD Redetermination for Vertebral Augmentation Update

AAPM joined efforts with nine other societies to share comments with the National Government Services Inc. regarding its recently published Future Local Coverage Determinations for Percutaneous Vertebral Augmentation for...
Continue reading
Topics:

Interagency Pain Research Coordinating Committee Meeting - November 2019

The Interagency Pain Research Coordinating Committee will hold its next meeting on November 18, 2019, and will be available on a videocast. For more information.  
Topics:

Bill to Help Prevent Drug Shortages Introduced by Senators Collins, Smith

U.S. Senator Susan Collins (R-ME), the Chairman of the Aging Committee, and Senator Tina Smith (D-MN) introduced the Mitigating Emergency Drug Shortages (MEDS) Act, legislation that would help increase the supplies of vi...
Continue reading

How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making?

This commentary responds to a case and examines pragmatic concerns about operating a busy outpatient practice in compliance with new laws that regulate opioid prescribing. Specifically, the article considers how regulati...
Continue reading

DEA Announces Additional Regulatory Steps to Address Opioid Epidemic

The Drug Enforcement Administration announced proposed regulations to improve DEA's ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further...
Continue reading
Topics:

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More